Akashi, Kengo <br/><br/>
Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice.  [electronic resource] 

 -  Arthritis research & therapy  05 2016 
 - 113 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-016-1011-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--toxicity<br/>Bleomycin--toxicity<br/>Collagen Type I--metabolism<br/>Disease Models, Animal<br/>Endothelin-1--metabolism<br/>Fibroblasts--metabolism<br/>Fibrosis--metabolism<br/>Immunohistochemistry<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Polymerase Chain Reaction<br/>Receptor, Endothelin B--metabolism<br/>Scleroderma, Systemic--metabolism<br/>Signal Transduction--physiology<br/>Skin--metabolism